Cover Image

Targeting microglial autophagic degradation of the NLRP3 inflammasome for identification of thonningianin A in Alzheimer's disease

Abstract Background NLRP3 inflammasome-mediated neuroinflammation plays a critical role in the pathogenesis and development of Alzheimer's disease (AD). Microglial autophagic degradation not only decreases the deposits of extracellular Aβ fibrils but also inhibits the activation of NRLP3 inflam...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xiao-Gang Zhou (Author), Wen-Qiao Qiu (Author), Lu Yu (Author), Rong Pan (Author), Jin-Feng Teng (Author), Zhi-Pei Sang (Author), Betty Yuen-Kwan Law (Author), Ya Zhao (Author), Li Zhang (Author), Lu Yan (Author), Yong Tang (Author), Xiao-Lei Sun (Author), Vincent Kam Wai Wong (Author), Chong-Lin Yu (Author), Jian-Ming Wu (Author), Da-Lian Qin (Author), An-Guo Wu (Author)
Format:	Book
Published:	BMC, 2022-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Tricin promoted ATG-7 dependent autophagic degradation of α-synuclein and dopamine release for improving cognitive and motor deficits in Parkinson's disease
by: Xingxia Wang, et al.
Published: (2023)

Tetrandrine, an Activator of Autophagy, Induces Autophagic Cell Death via PKC-α Inhibition and mTOR-Dependent Mechanisms
by: Vincent Kam Wai Wong, et al.
Published: (2017)

Berberine Protects Against NLRP3 Inflammasome via Ameliorating Autophagic Impairment in MPTP-Induced Parkinson's Disease Model
by: Shuxuan Huang, et al.
Published: (2021)

Licochalcone B, a Natural Autophagic Agent for Alleviating Oxidative Stress-Induced Cell Death in Neuronal Cells and <i>Caenorhabditis elegans</i> Models
by: Liqun Qu, et al.
Published: (2022)

The crosstalk between NLRP3 inflammasome and gut microbiome in atherosclerosis
by: Xiao-Nan Zhang, et al.
Published: (2022)

Melatonin Reduces NLRP3 Inflammasome Activation by Increasing α7 nAChR-Mediated Autophagic Flux
by: Víctor Farré-Alins, et al.
Published: (2020)

Redox Regulation of Microglial Inflammatory Response: Fine Control of NLRP3 Inflammasome through Nrf2 and NOX4
by: Alejandra Palomino-Antolín, et al.
Published: (2023)

Pomiferin targets SERCA, mTOR, and P-gp to induce autophagic cell death in apoptosis-resistant cancer cells, and reverses the MDR phenotype in cisplatin-resistant tumors in vivo
by: Yuan-Qing Qu, et al.
Published: (2023)

Effect of NLRP3 inflammasome induced astrocyte phenotype alteration in morphine tolerance
by: Zhenyu Yuan, et al.
Published: (2024)

Research progress of NLRP3 inflammasome in the pathogenesis of psoriasis
by: Siman SHI, et al.
Published: (2022)

Formononetin Administration Ameliorates Dextran Sulfate Sodium-Induced Acute Colitis by Inhibiting NLRP3 Inflammasome Signaling Pathway
by: Dacheng Wu, et al.
Published: (2018)

Acetate Downregulates the Activation of NLRP3 Inflammasomes and Attenuates Lung Injury in Neonatal Mice With Bronchopulmonary Dysplasia
by: Qian Zhang, et al.
Published: (2021)

Ethyl Pyruvate Attenuates Microglial NLRP3 Inflammasome Activation via Inhibition of HMGB1/NF-κB/miR-223 Signaling
by: Melis Olcum, et al.
Published: (2021)

NLRP3 inflammasome and its inhibitors: a review
by: Bo-Zong eShao, et al.
Published: (2015)

Corrigendum to "Formononetin Administration Ameliorates Dextran Sulfate Sodium-Induced Acute Colitis by Inhibiting NLRP3 Inflammasome Signaling Pathway"
by: Dacheng Wu, et al.
Published: (2018)

The NLRP3 inflammasome is involved in resident intruder paradigm-induced aggressive behaviors in mice
by: Qingying Yu, et al.
Published: (2023)

The role of NLRP3 inflammasome in type 2 inflammation related diseases
by: Shenming Xu, et al.
Published: (2024)

Natural Products that Target the NLRP3 Inflammasome to Treat Fibrosis
by: Nan Ding, et al.
Published: (2020)

NLRP3 Inflammasome Pharmacological Inhibitors in Glycyrrhiza for NLRP3-Driven Diseases Treatment: Extinguishing the Fire of Inflammation
by: Wang Z, et al.
Published: (2022)

Neurodegenerative Disease and the NLRP3 Inflammasome
by: Jonathan A. Holbrook, et al.
Published: (2021)

NLRP3 inflammasome in metabolic syndrome
by: Fang Wang, et al.
Published: (2021)

Spotlight on the NLRP3 inflammasome pathway
by: Groslambert M, et al.
Published: (2018)

The role of the NLRP3 inflammasome in gout
by: Sarah R Kingsbury, et al.
Published: (2011)

Chrysin Attenuates the NLRP3 Inflammasome Cascade to Reduce Synovitis and Pain in KOA Rats
by: Liao T, et al.
Published: (2020)

Role of NLRP3 Inflammasome in Lupus Nephritis and Therapeutic Targeting by Phytochemicals
by: Dantong Wu, et al.
Published: (2021)

Autophagy Induced by Micheliolide Alleviates Acute Irradiation-Induced Intestinal Injury via Inhibition of the NLRP3 Inflammasome
by: Dong-ming Wu, et al.
Published: (2022)

The NLRP3 Inflammasome in Non-Alcoholic Fatty Liver Disease and Steatohepatitis: Therapeutic Targets and Treatment
by: Lili Yu, et al.
Published: (2022)

Tanreqing injection inhibits dengue virus encephalitis by suppressing the activation of NLRP3 inflammasome
by: Hefei Huang, et al.
Published: (2024)

Identification of ethyl pyruvate as a NLRP3 inflammasome inhibitor that preserves mitochondrial integrity
by: Sujun Li, et al.
Published: (2018)

Parthenolide ameliorates 3-nitropropionic acid-induced Huntington's disease-like aberrations via modulating NLRP3 inflammasome, reducing microglial activation and inducing astrocyte shifting
by: Mona E. Noureldeen, et al.
Published: (2024)

Andrographolide Attenuates NLRP3 Inflammasome Activation and Airway Inflammation in Exacerbation of Chronic Obstructive Pulmonary Disease
by: Yu Y, et al.
Published: (2024)

The role of NLRP3 inflammasome-mediated pyroptosis in ischemic stroke and the intervention of traditional Chinese medicine
by: Jia-Xin Long, et al.
Published: (2023)

The Role of NLRP3 Inflammasome in Alzheimer's Disease and Potential Therapeutic Targets
by: Tao Liang, et al.
Published: (2022)

NLRP3 inflammasome activation by Paracoccidioides brasiliensis.
by: Aldo Henrique Tavares, et al.
Published: (2013)

The role of NLRP3 inflammasome in hepatocellular carcinoma
by: Huijie Zhao, et al.
Published: (2023)

Acute Lung Injury and the NLRP3 Inflammasome
by: Gu W, et al.
Published: (2024)

Tanshinone I specifically suppresses NLRP3 inflammasome activation by disrupting the association of NLRP3 and ASC
by: Jia Zhao, et al.
Published: (2023)

Hydrogen-Rich Saline Inhibits NLRP3 Inflammasome Activation and Attenuates Experimental Acute Pancreatitis in Mice
by: Jian-Dong Ren, et al.
Published: (2014)

Yupingfeng San Inhibits NLRP3 Inflammasome to Attenuate the Inflammatory Response in Asthma Mice
by: Xue Liu, et al.
Published: (2017)

Th1 cells reduce the osteoblast-like phenotype in valvular interstitial cells by inhibiting NLRP3 inflammasome activation in macrophages
by: Jing Lu, et al.
Published: (2024)